KPJ Healthcare Berhad
A leader in Malaysia's challenging healthcare services industry
- /
- KPJ Events
- News Detail
News Detail:
Private chain of hospitals to utilize cognitive computing platform |
| 24-02-2018 |
In October 2017, KPJ Healthcare Berhad implemented Watson for Oncology in five of its specialist hospitals in Malaysia: KPJ Damansara, KPJ Ampang Puteri, KPJ Johor, KPJ Ipoh and KPJ Sabah. "We believe that the introduction of this platform will increase the hospital's capability to provide cancer patients with therapeutic options that are based on good medical evidence," said Dato' Amiruddin Abdul Satar, president and managing director of KPJ Healthcare, Malaysia. The investment in cognitive technology is in line with the hospital group's vision to become an oncology hub in the country and region, he continued.
Watson for Oncology is a cognitive computing platform trained by the US based Memorial Sloan Kettering Cancer Center (MSKCC), a cancer centre that provides patient care, leading-edge research and educational programs. The platform is trained to provide insights that can help healthcare providers deliver better evidence-based cancer treatment. The unique platform was developed by IBM in collaboration with MSKCC. It can summarize the key medical attributes of a patient and provide information to oncologists to help them deliver better-personalized treatment. Watson for Oncology ranks the treatment options, linking to peer-reviewed studies that have been curated by MSK. Additionally, it provides a large body of medical literature for a clinician to consider, drawing on more than 300 medical journals, more than 200 textbooks and nearly 15 million pages of text to provide insights about different treatment options.For now, Watson for Oncology is implemented in only five KPJ hospitals—these are the hospitals under KPJ that have cancer centres—but it may be introduced to their other hospitals as well, depending on the feedback received, said Amiruddin. There will be no extra cost charged to patients with the implementation of this platform, he said. KPJ absorbed all the cost as part of their effort to improve the provision of care. When asked if the cognitive computing platform may be biased towards medication that are more popular in the US, oncologist Dr Aminudin Rahman emphasized that the role of the platform is to assist in the decision-making process and will not replace the role of doctors. Doctors will weigh the treatment options and supporting evidence presented by the platform, and make the final treatment decision together with the patients. Thus, there will be less risk of bias, he noted. Currently, Watson for Oncology is able to assist doctors in the areas of breast, lung, colorectal, cervical, ovarian, gastric, prostate and bladder cancers. The cognitive computing platform is currently in use at more than 80 hospitals and 11 countries around the world. Both Amiruddin and Aminudin were speaking at the media launch event for the adoption of the Watson for Oncology by KPJ Healthcare, held in Kuala Lumpur recently. |
BACK
Quick Links
Corporate Profile
Speciality Centres
Site Links
- View More
Copyright © KPJ Healthcare Berhad. All Rights Reserved.Powered by: D Economy System Sdn Bhd